Related Experiment Video
Updated: Oct 14, 2025

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Zero-contrast PTRA and stenting for child with TRAS: A case report
Yang Xie1, Xingwei He1, Liru Qiu2
1Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zero-contrast percutaneous transluminal renal angioplasty (PTRA) successfully treated renal artery stenosis (RAS) in a kidney transplant patient with chronic kidney disease (CKD). This novel approach avoids nephropathy from contrast agents.
Area of Science:
- Nephrology
- Interventional Cardiology
- Radiology
Background:
- Transplant-associated renal artery stenosis (TRAS) is a common complication post-kidney transplant.
- Percutaneous transluminal renal angioplasty (PTRA) is effective for TRAS but limited in patients with chronic kidney disease (CKD) due to contrast-induced nephropathy.
Observation:
- A 14-year-old kidney transplant recipient with RAS initially underwent balloon dilation.
- One and a half years later, the patient received zero-contrast PTRA and stenting.
- Guidance was provided by external ultrasound and intravascular ultrasound (IVUS), referencing a prior peripheral angiography (PAG) image.
Findings:
- Successful stent implantation significantly increased the renal artery lumen's cross-sectional area.
- Post-procedure, blood pressure and serum creatinine levels decreased and remained stable during follow-up.
Implications:
- Zero-contrast PTRA guided by external ultrasound and IVUS is a feasible alternative for TRAS patients with compromised renal function or contrast allergies.
- This technique offers a safer treatment option, mitigating risks associated with iodinated contrast agents in vulnerable populations.
More Related Videos
06:26Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023